Canopy Growth (TSX:WEED) Sets Profit Goal for Its Canadian Operations

As it shifts its focus to the U.S. market, Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is going to need to run a much tighter ship in Canada.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has done a great job of growing its sales in recent quarters. However, recording a positive earnings result has proven to be much more elusive and difficult for the company. When it does post a positive net income figure, it’s usually the result of non-operational items that give the company a boost, which isn’t something investors can rely on from one period to the next.

That also means that cash flows aren’t particularly strong either, and the problem is that it could lead to the company issuing more shares, which will result it downward pressure on its share price. That’s something the company wants to avoid, especially with its stock not performing very well lately. As of the end of last week, Canopy Growth’s share price has declined more than 18% since the beginning of May.

While the stock is still up around 50% year to date, it’s clear that investors have been a bit more hesitant to buy Canopy Growth. One of those reasons is likely the inconsistency in its financials. The company has had to deal with a big miss on revenues late last year, and with a weak bottom line, there are plenty of reasons for investors to be bearish on the company’s recent performance.

There is still plenty of hope for the future, especially if its deal with Acreage Holdings goes through, but there’s still lots of uncertainty surrounding it.

Planning for profitability

One of the ways that the company can try and improve its position with investors is to try and focus on profitability, which is what the company plans to do. Last week, Canopy Growth’s CFO Mike Lee said, “We’re very clear that when it comes to Canada as a stand-alone business that we expect to be EBITDA positive in the next 18 months.”

EBITDA is a more realistic target for the company than net income. It’s also likely more relevant for investors, as a good EBITDA number will better reflect aspects of the business that the company has control over during the short term, and will help indicate the direction of its cash flows as well.

Cash is always an important consideration because a lack of it means more debt or equity that needs to be raised in order to fund expansion, and Canopy Growth is looking to minimize its use of equity issues.

In order to finance its operations, the company is looking at many options, including setting up a real estate investment trust or using secured financing. It’s good news for investors who may worry about future dilution, but it also underscores why it’s important for Canopy Growth to be EBITDA positive and be able to fund its own growth, at least in Canada.

It’s clear that the company has set its sights onto the U.S., where it’ll likely continue to burn through cash as it looks to dominate that market in the years to come. And that’s where cleaning up its house in Canada and ensuring that operations are generating cash will be key in helping the company grow in other parts of the world.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »